Sign In
Buy SGEN
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Seagen to Host Conference Call and Webcast Discussion of Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023
08:00am, Thursday, 19'th Jan 2023
BOTHELL, Wash.--( BUSINESS WIRE )--Seagen Inc. (Nasdaq: SGEN) today announced that it will report its fourth quarter and full year 2022 financial results on Wednesday, February 15, 2023 after the clos
100 Best Stocks Of 2022: Oil Stocks And Medicals Shine
06:00pm, Friday, 30'th Dec 2022
Medical and energy companies, including oil stocks, lead the list of the 100 best stocks in 2022. The post 100 Best Stocks Of 2022: Oil Stocks And Medicals Shine appeared first on Investor's Business
Have A Look At William Blair's Top Biotech Picks For 2023
06:32pm, Sunday, 25'th Dec 2022 Benzinga
William Blair & Company's report outlined some key themes and significant trends to monitor while entering 2023, providing its top stock ideas for the upcoming 12-month period.
Seagen Inc.'s (NASD
Seagen: 2023 Shaping Up To Be A Breakout Year
05:31pm, Thursday, 22'nd Dec 2022
SGEN has been under pressure since a rumored takeover deal by pharmaceutical giant Merck & Co. fell through last summer. The company last reported its Q3 earnings with stronger than expected sales, wi
Merck (MRK), Seagen Keytruda-Padcev sBLAs Get FDA Priority Tag
03:22pm, Wednesday, 21'st Dec 2022 Zacks Investment Research
Merck (MRK) and Seagen's (SGEN) sBLAs seek approval of Padcev plus Keytruda for locally advanced or metastatic urothelial cancer in patients who are not eligible for cisplatin-containing chemotherapy.
Top Stocks In Multiple Industries Build Bases As Market Gains Strength
03:01pm, Friday, 02'nd Dec 2022
An array of top stocks in a wide variety of industries are building cup bases as the stock market recovers. The post Top Stocks In Multiple Industries Build Bases As Market Gains Strength appeared fir
2 Growth Stocks to Buy if the Bear Market Continues in 2023
02:53pm, Thursday, 01'st Dec 2022 The Motley Fool
These stocks aren't bargain buys just yet, but they could be soon.
These Are the Five Best and Worst Performing Healthcare Stocks in October 2022
08:02pm, Monday, 28'th Nov 2022
The healthcare sector has gained momentum following the COVID-19 pandemic. Several companies gained early regulatory approval for developing COVID-19 drugs and distributing vaccines.
Hot Biotech Stocks Rise Into Leadership; Pass Buy Points Or Build Bases
02:10pm, Friday, 25'th Nov 2022
Top biotech stocks surge within the IBD 50. Some pass buy points while others build bases.
Expert Ratings for Seagen
01:01pm, Monday, 21'st Nov 2022 Benzinga
Over the past 3 months, 12 analysts have published their opinion on Seagen (NASDAQ:SGEN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company
The Zacks Analyst Blog Highlights Merrimack Pharmaceuticals, Moderna and Seagen
11:56am, Thursday, 17'th Nov 2022 Zacks Investment Research
Highlights Merrimack Pharmaceuticals, Moderna and Seagen are included in this Analyst Blog.
Biotech Stock Roundup: MACK Up on Study Data, MRNA Offers Vaccine Update & More
04:28pm, Wednesday, 16'th Nov 2022 Zacks Investment Research
Pipeline updates from MACK and MRNA are the key highlights from the biotech sector during the past week.
Did You Buy And Not Sell Friday? You're Doing It Wrong - Again
08:33am, Monday, 14'th Nov 2022 Seeking Alpha
This week saw quite a bit of volatility yet the VIX continues to fall. Read more to see why I expect this week we will see quite a comedown.
Seagen (SGEN) Adcetris Label Expansion OK'd, New CEO Named
03:23pm, Friday, 11'th Nov 2022 Zacks Investment Research
The FDA approves Seagen's (SGEN) Adcetris for a new indication, treating pediatric patients with previously untreated high-risk Hodgkin lymphoma. The company also appoints a new CEO.
Seagen (SGEN) Adcetris Label Expansion OK'd, New CEO Named
12:02pm, Friday, 11'th Nov 2022
The FDA approves Seagen's (SGEN) Adcetris for a new indication, treating pediatric patients with previously untreated high-risk Hodgkin lymphoma. The company also appoints a new CEO.
